Injective brings SharpLink’s $1.3 billion ETH treasury fully on-chain

Injective brings SharpLink’s $1.3 billion ETH treasury fully on-chain

Bringing SharpLink’s massive ETH portfolio onto the blockchain opens new doors for institutional DeFi and onchain asset management.

Share

Add us on Google
by Vivian Nguyen | Powered by Gloria

Injective has launched on-chain SBET, the first tokenized digital asset treasury (DAT) that transforms SharpLink Gaming’s Ethereum holdings into an onchain instrument, according to the project’s announcement.

SharpLink Gaming, the largest corporate holder of Ethereum, has amassed 360,807 ETH, valued at around $1.3 billion at current market prices, since launching its treasury strategy last month.

According to Injective, the SBET digital asset treasury is powered by Injective’s iAssets framework, which allows real-world assets to operate as programmable primitives, with built-in governance, trading, staking, and cross-protocol composability.

“Through Injective’s iAssets framework, SBET is no longer a static equity but a programmable financial primitive,” said Injective in a statement. “From the very first day of issuance, it can be deployed across lending markets, used as collateral, incorporated into derivatives, or embedded into entirely new structured products without the capital inefficiencies or settlement delays that exist in traditional finance.”

The move positions Injective at the forefront of a growing shift as institutional capital begins migrating to onchain infrastructure.

“Injective’s vision is to merge the traditional and on-chain worlds, creating a financial system that is not only open and accessible but also far more efficient. The launch of SBET as an onchain digital asset treasury is a clear demonstration of that mission,” Injective stated.

Discussing Injective’s new product, Matt Sheffield, Director of Trading at FalconX, the largest institutional crypto prime brokerage, noted that digital asset treasuries are helping bridge the gap between traditional and on-chain markets by enabling more structured and transparent access to crypto.

“The launch of an on-chain product tracking SBET by Injective marks a notable milestone, bringing the capital efficiency of public markets to DeFi infrastructure in a composable and transparent way,” Sheffield said.

The launch of on-chain SBET follows Injective’s earlier rollout of iAssets tied to traditional equities, including Nvidia, Meta, and Robinhood, alongside gold, oil, and FX markets — all tradeable 24/7 and programmable from launch.

DEFI

Injective brings SharpLink’s $1.3 billion ETH treasury fully on-chain

Injective brings SharpLink’s $1.3 billion ETH treasury fully on-chain

Bringing SharpLink’s massive ETH portfolio onto the blockchain opens new doors for institutional DeFi and onchain asset management.

by Vivian Nguyen | Powered by Gloria

Share

Add us on Google

Injective has launched on-chain SBET, the first tokenized digital asset treasury (DAT) that transforms SharpLink Gaming’s Ethereum holdings into an onchain instrument, according to the project’s announcement.

SharpLink Gaming, the largest corporate holder of Ethereum, has amassed 360,807 ETH, valued at around $1.3 billion at current market prices, since launching its treasury strategy last month.

According to Injective, the SBET digital asset treasury is powered by Injective’s iAssets framework, which allows real-world assets to operate as programmable primitives, with built-in governance, trading, staking, and cross-protocol composability.

“Through Injective’s iAssets framework, SBET is no longer a static equity but a programmable financial primitive,” said Injective in a statement. “From the very first day of issuance, it can be deployed across lending markets, used as collateral, incorporated into derivatives, or embedded into entirely new structured products without the capital inefficiencies or settlement delays that exist in traditional finance.”

The move positions Injective at the forefront of a growing shift as institutional capital begins migrating to onchain infrastructure.

“Injective’s vision is to merge the traditional and on-chain worlds, creating a financial system that is not only open and accessible but also far more efficient. The launch of SBET as an onchain digital asset treasury is a clear demonstration of that mission,” Injective stated.

Discussing Injective’s new product, Matt Sheffield, Director of Trading at FalconX, the largest institutional crypto prime brokerage, noted that digital asset treasuries are helping bridge the gap between traditional and on-chain markets by enabling more structured and transparent access to crypto.

“The launch of an on-chain product tracking SBET by Injective marks a notable milestone, bringing the capital efficiency of public markets to DeFi infrastructure in a composable and transparent way,” Sheffield said.

The launch of on-chain SBET follows Injective’s earlier rollout of iAssets tied to traditional equities, including Nvidia, Meta, and Robinhood, alongside gold, oil, and FX markets — all tradeable 24/7 and programmable from launch.

Add us on Google `; } function createMobileArticle(article) { const displayDate = getDisplayDate(article); const editorSlug = article.editor ? article.editor.toLowerCase().replace(/\s+/g, '-') : ''; const captionHtml = article.imageCaption ? `

${article.imageCaption}

` : ''; const authorHtml = article.isPressRelease ? '' : `
by ${article.editor} | Powered by Gloria
`; return `
${article.title} ${captionHtml}

${article.title}

${article.subheadline ? `

${article.subheadline}

` : ''}
${createSocialShare()}
${authorHtml}
${article.content}
`; } function createDesktopArticle(article, sidebarAdHtml) { const editorSlug = article.editor ? article.editor.toLowerCase().replace(/\s+/g, '-') : ''; const displayDate = getDisplayDate(article); const captionHtml = article.imageCaption ? `

${article.imageCaption}

` : '
'; const categoriesHtml = article.categories.map((cat, i) => { const separator = i |' : ''; return `${cat}${separator}`; }).join(''); const desktopAuthorHtml = article.isPressRelease ? '' : `
by ${article.editor} | Powered by Gloria
`; return `
${categoriesHtml}

${article.title}

${article.title}
${article.subheadline ? `

${article.subheadline}

` : ''}
${desktopAuthorHtml} ${createSocialShare()}
${captionHtml}
${article.content}
`; } function loadMoreArticles() { if (isLoading || !hasMore) return; isLoading = true; loadingText.classList.remove('hidden'); // Build form data for AJAX request const formData = new FormData(); formData.append('action', 'cb_lovable_load_more'); formData.append('current_post_id', lastLoadedPostId); formData.append('primary_cat_id', primaryCatId); formData.append('before_date', lastLoadedDate); formData.append('loaded_ids', loadedPostIds.join(',')); fetch(ajaxUrl, { method: 'POST', body: formData }) .then(response => response.json()) .then(data => { isLoading = false; loadingText.classList.add('hidden'); if (data.success && data.has_more && data.article) { const article = data.article; const sidebarAdHtml = data.sidebar_ad_html || ''; // Check for duplicates if (loadedPostIds.includes(article.id)) { console.log('Duplicate article detected, skipping:', article.id); // Update pagination vars and try again lastLoadedDate = article.publishDate; loadMoreArticles(); return; } // Add to mobile container mobileContainer.insertAdjacentHTML('beforeend', createMobileArticle(article)); // Add to desktop container with fresh ad HTML desktopContainer.insertAdjacentHTML('beforeend', createDesktopArticle(article, sidebarAdHtml)); // Update tracking variables loadedPostIds.push(article.id); lastLoadedPostId = article.id; lastLoadedDate = article.publishDate; // Execute any inline scripts in the new content (for ads) const newArticle = desktopContainer.querySelector(`article[data-article-id="${article.id}"]`); if (newArticle) { const scripts = newArticle.querySelectorAll('script'); scripts.forEach(script => { const newScript = document.createElement('script'); if (script.src) { newScript.src = script.src; } else { newScript.textContent = script.textContent; } document.body.appendChild(newScript); }); } // Trigger Ad Inserter if available if (typeof ai_check_and_insert_block === 'function') { ai_check_and_insert_block(); } // Trigger Google Publisher Tag refresh if available if (typeof googletag !== 'undefined' && googletag.pubads) { googletag.cmd.push(function() { googletag.pubads().refresh(); }); } } else if (data.success && !data.has_more) { hasMore = false; endText.classList.remove('hidden'); } else if (!data.success) { console.error('AJAX error:', data.error); hasMore = false; endText.textContent = 'Error loading more articles'; endText.classList.remove('hidden'); } }) .catch(error => { console.error('Fetch error:', error); isLoading = false; loadingText.classList.add('hidden'); hasMore = false; endText.textContent = 'Error loading more articles'; endText.classList.remove('hidden'); }); } // Set up IntersectionObserver const observer = new IntersectionObserver(function(entries) { if (entries[0].isIntersecting) { loadMoreArticles(); } }, { threshold: 0.1 }); observer.observe(loadingTrigger); })();